Perrigo is an over-the-counter (OTC) consumer goods and pharmaceutical company, and it offers consumers and customers high-quality products at affordable prices. The company is also a leading provider of branded OTC products and generic extended topical prescription products, and receives royalties from the multiple sclerosis drug Tysabri. Perrigo provides quality, affordable healthcare products across a wide variety of product categories and geographies primarily in North America, Europe, and Australia, as well as other key markets including Israel and China.

In 2005 Perrigo acquired Agis Industries Ltd, an Israeli generic pharmaceuticals company. Perrigo Israel develops, manufactures and markets generic drugs and medical and diagnostic equipment. More than 500 of its employees are employed in a generic drug development and manufacturing plant located in Shoham Industrial Park. At Yeruham, the company develops and manufactures pharmaceuticals following complex technologies, such as foams, nasal sprays and hormonal products, in addition to a wide range of dermatological, vaginal and other products.